Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...

Office of Nuclear Energy and the National Reactor Innovation Center (NRIC) have announced the first four developers ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Spurred by increasing public recognition of the dangers posed by police responses to mental health and substance use crises—particularly for people of color and individuals with ...

LOS ANGELES — While at a career fair, Ivan Parra took time to admire some of the STEM projects that were showcased. “There’s a lot of opportunities here — especially, there’s a booth about solar ...

A new study conducted by researchers from the University of Potsdam and the University of Cologne has deciphered the step-by-step assembly of the eukaryotic proteasome. Eukaryotes are organisms whose ...

Rhode Island Rep. Stephen Casey introduced a House bill on Feb. 27, which was referred to the House Corporations Committee, as reported by CFO Dive. Louisiana Rep. Gerald "Beau" Beaullieu IV pre-filed ...

Shiga-like toxin-producing E. coli-induced hemolytic uremic syndrome (STEC-HUS) is a rare but severe disease characterized by microangiopathic hemolysis, thrombocytopenia, and renal failure. No ...

Add Yahoo as a preferred source to see more of our stories on Google. However, the final act of that film reveals that Stu was indeed just AI and not one of the killers in Scream 7. But he almost was ...

The big question going into Scream 7 was about the involvement of Stu Macher, Roman Bridger, and Dewey Riley. As we all know, all three of them died in previous movies. Well, at least two of them were ...

Aberrant complement activation can cause damage to newly formed fetal-derived structures and excessive inflammatory response at the feto-maternal interface, contributing to pregnancy-related ...

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but they don't work for up to 4 of every 10 patients. New research led by ...